The company has developed and introduced the medical product development system that accurately and quickly reacts to the changes of the pharmaceutical market of the Central Asia and allows, in time, to provide the population with necessary, high-quality and affordable medicines. Thus, the way of new preparation registration guarantees its safety and pharmacological efficiency.

Development and introduction of new medicines is constantly carried out in cooperation with research organizations of the Ministry of Health of the Republic of Uzbekistan and with leading universities and the National Academy of Sciences. There are creative relationships with research organizations of Russia as well as with many neighboring and overseas companies.

The major shares of the socially significant and highly demanded drugs of the company are: antibiotics, cardiovascular drugs, analgesics, anti-inflammatory, central nervous system treatment drugs, etc